Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 985 products on this category.

Product data	Purity	Price range	Estimated delivery
Olaparib Impurity 16 (Dimethyl phosphite) REF: 4Z-O-032018CAS: 868-85-9	- - -	To inquire	Mon 23 Dec 24
Lenvatinib Impurity 35 REF: 4Z-L-124041	- - -	To inquire	Mon 23 Dec 24
Carfilzomib Impurity 17 REF: 4Z-C-121020CAS: 247068-83-3	- - -	To inquire	Mon 23 Dec 24
Palbociclib Impurity 14 REF: 4Z-P-196018CAS: 51534-87-3	- - -	To inquire	Mon 23 Dec 24
Palbociclib Impurity 28 REF: 4Z-P-196032	- - -	To inquire	Mon 23 Dec 24
Bestatin Impurity 1 REF: 4Z-B-119004CAS: 62023-63-6	- - -	To inquire	Mon 23 Dec 24
N-Nitroso Olaparib Impurity 13 REF: 4Z-O-032078CAS: 2742659-74-9	- - -	To inquire	Mon 23 Dec 24
Carfilzomib Impurity 47 REF: 4Z-C-121050CAS: 82732-07-8	- - -	To inquire	Mon 23 Dec 24
Nintedanib N-Glucuronide-2 REF: 4Z-N-066037	- - -	To inquire	Mon 23 Dec 24
Carfilzomib Impurity 25 REF: 4Z-C-121028CAS: 2049024-37-3	- - -	To inquire	Mon 23 Dec 24
Enzalutamide Impurity 13 REF: 4Z-E-068026	- - -	To inquire	Mon 23 Dec 24
Nintedanib Impurity 55 REF: 4Z-N-066073	- - -	To inquire	Mon 23 Dec 24
Lenvatinib Impurity 38 Chloride REF: 4Z-L-124044CAS: 6118-33-8	- - -	To inquire	Mon 23 Dec 24
Palbociclib Impurity 7 REF: 4Z-P-196011CAS: 827022-35-5	- - -	To inquire	Mon 23 Dec 24
N2-Nitroso Nintedanib REF: 4Z-N-066112	- - -	To inquire	Mon 23 Dec 24
Olaparib Impurity 32 REF: 4Z-O-032036	- - -	To inquire	Mon 23 Dec 24
Palbociclib Impurity 37 REF: 4Z-P-196044CAS: 2144748-14-9	- - -	To inquire	Mon 23 Dec 24
Fulvestrant Impurity 13 REF: 4Z-F-3135	- - -	To inquire	Mon 23 Dec 24
Enzalutamide Impurity 64 REF: 4Z-E-068080	- - -	To inquire	Mon 23 Dec 24
Nintedanib Impurity 76 REF: 4Z-N-066087	- - -	To inquire	Mon 23 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Olaparib Impurity 16 (Dimethyl phosphite)

Ref: 4Z-O-032018

Lenvatinib Impurity 35

Ref: 4Z-L-124041

Carfilzomib Impurity 17

Ref: 4Z-C-121020

Palbociclib Impurity 14

Ref: 4Z-P-196018

Palbociclib Impurity 28

Ref: 4Z-P-196032

Bestatin Impurity 1

Ref: 4Z-B-119004

N-Nitroso Olaparib Impurity 13

Ref: 4Z-O-032078

Carfilzomib Impurity 47

Ref: 4Z-C-121050

Nintedanib N-Glucuronide-2

Ref: 4Z-N-066037

Carfilzomib Impurity 25

Ref: 4Z-C-121028

Enzalutamide Impurity 13

Ref: 4Z-E-068026

Nintedanib Impurity 55

Ref: 4Z-N-066073

Lenvatinib Impurity 38 Chloride

Ref: 4Z-L-124044

Palbociclib Impurity 7

Ref: 4Z-P-196011

N2-Nitroso Nintedanib

Ref: 4Z-N-066112

Olaparib Impurity 32

Ref: 4Z-O-032036

Palbociclib Impurity 37

Ref: 4Z-P-196044

Fulvestrant Impurity 13

Ref: 4Z-F-3135

Enzalutamide Impurity 64

Ref: 4Z-E-068080

Nintedanib Impurity 76

Ref: 4Z-N-066087